Patient views and experiences of making adverse drug reaction reports to the Yellow Card Scheme in the UK.
about
Patients views and experiences in online reporting adverse drug reactions: findings of a national pilot study in Japan.Pharmacovigilance in oncology: evaluation of current practice and future perspectives.The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective.What can we learn from parents about enhancing participation in pharmacovigilance?A plea for a more epidemiological and patient-oriented pharmacovigilance.Experiences with adverse drug reaction reporting by patients: an 11-country survey.Adverse Drug Reaction Reporting Practices Among United Arab Emirates Pharmacists and Prescribers.Patient Reporting of Adverse Drug Reactions: An International Survey of National Competent Authorities' Views and Needs.Public confidence in ADR identification and their views on ADRreporting: mixed methods study.Are consumers ready to take part in the Pharmacovigilance System?--a Portuguese preliminary study concerning ADR reporting.Feedback for patients reporting adverse drug reactions; satisfaction and expectations.Survey of patients' experiences and their certainty of suspected adverse drug reactions.Effect of pharmacist involvement on patient reporting of adverse drug reactions: first Italian study.Survey to assess public awareness of patient reporting of adverse drug reactions in Great Britain.Attitudes and opinion about adverse drug events of women living in a city of south Italy.
P2860
Q35043774-9F482C79-2A96-4A87-B39C-A00ECA629019Q35183601-FFA00732-8C3F-4B81-B98A-FFFE018AB815Q35624610-AA2DBE1C-868D-440D-94BF-DB4308283DB0Q36729977-1EB769C5-FF75-40FE-9905-5352638120ADQ37902956-4B31143E-944D-4CEA-8ACA-281B184A953EQ37965625-CD2D0E54-311B-4320-98B7-34DA193AD37DQ38626958-34658674-366E-4013-97D5-BE11617B181DQ39434726-AFBEB4DE-40CE-4FB6-84AF-F9DAB4262A82Q40478509-EE84A48E-617A-4768-BE8D-9FCD9FBA67EEQ40907155-A27FEF06-67E4-4917-830D-391AA8942F1CQ41232974-5A9B5E9E-0724-4D83-85B5-A513B19BD68DQ41598140-F998CFDF-C1EA-4604-BF7B-E55649F98584Q44356753-707D5411-5703-438C-BBC2-43EF0CED970FQ50433906-6064D03F-4B9F-4FC3-AE34-5BF2B5608FEDQ51272096-0D9A8264-312F-4485-86A9-6195D0158351
P2860
Patient views and experiences of making adverse drug reaction reports to the Yellow Card Scheme in the UK.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Patient views and experiences ...... Yellow Card Scheme in the UK.
@en
Patient views and experiences ...... Yellow Card Scheme in the UK.
@nl
type
label
Patient views and experiences ...... Yellow Card Scheme in the UK.
@en
Patient views and experiences ...... Yellow Card Scheme in the UK.
@nl
prefLabel
Patient views and experiences ...... Yellow Card Scheme in the UK.
@en
Patient views and experiences ...... Yellow Card Scheme in the UK.
@nl
P2093
P2860
P50
P356
P1476
Patient views and experiences ...... Yellow Card Scheme in the UK.
@en
P2093
Amanda J Lee
Christine M Bond
Elizabeth Murphy
Heather Fortnum
Janet Krska
Margaret C Watson
Philip C Hannaford
Yellow Card Study Collaboration
P2860
P304
P356
10.1002/PDS.2117
P577
2011-02-17T00:00:00Z